Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VECTRA study of STP938 in high-risk essential thrombocythaemia after hydroxycarbamide intolerance or resistance
2024-519964-42-00Phase 2Authorised
- Sponsor
- StepPharma
- Start
- Jul 2025
- Modality
- Small Molecules
- Countries
- 5
01
Overview
Phase 2, open-label, single-arm trial of dencatistat in thrombocythemia, sponsored by StepPharma. Planned start Jul 2025; status: authorised.
02
Drugs
dencatistat
03
Conditions
thrombocythemia
Beyond the preview
Go deeper on 2024-519964-42-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-519964-42-00.